Skip to main content

Ardelyx, Inc. (ARDX)

Sector
Biotechnology
Last price
$3.18
As of

Kresmion compiles this page from ARDX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

ARDELYX, INC. (ARDX): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q3 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-03.

As of . Source: SEC EDGAR filings for ARDX. Method and limitations.

COMPANY DOSSIER

See the full ARDX dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for ARDX on one page. Preview it with sample data, then open it live with a free account.

Preview the ARDX dossier

Active events for ARDX

FREE, NO ACCOUNT

Every event on ARDX, as it fires

You are seeing 5 of 14 events recorded on ARDX since 2026-06-10.

The five above landed across 2 days. The other 9 were recorded on 2 other days. 10 of the 14 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

ARDX positions held by the managers we follow (2026Q3)

What the managers we follow bought and sold in Q2 2026

Manager / securityMarket value% of reported value
RENAISSANCE TECHNOLOGIES LLC FundCUSIP 039697107 · 2026Q3$407K0.00%

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, ARDX

More data on ARDX

ARDX against its peers

ARDX's operating margin of -10.1% ranks in the 58th percentile of 12 Biotechnology sub-industry peers, fiscal period ending 2025-12-31.

MetricARDXPeer medianPercentilen
Revenue FY407M USD94.4M USD9612
Gross margin90.3%n/an/a2
Operating margin-10.1%-71.0%5812
Net margin-15.1%-66.2%5812
Return on equity-36.9%-45.8%5317
1 year-44.9%15.3%1417

Peers (19): ORIC, LXRX, GLUE, PRME, IRWD, SLDB, AURA, SNDX, JANX, RIGL, SGMT, MGTX, XOMA.D, CRVS, TBPH, NVCT, ACHV, PHAR, DBVT. Left out: OBX (no annual filing), LTGO (no annual filing), BBTX (no annual filing), ATTO (no annual filing), IVA (period gap), AKTS (no annual filing). Fiscal period ending 2025-12-31. Every figure is one full fiscal year read from one annual filing (ARDX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in ARDX on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on ARDX in the last 180 days.

Upstream: SEC EDGAR filings for ARDX

Kresmion, "ARDELYX, INC. (ARDX) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/ARDX. Upstream data: SEC EDGAR filings for ARDX.

Link to this data (HTML):

<a href="https://kresmion.com/research/ARDX">ARDELYX, INC. (ARDX) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow ARDX on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to ARDX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the ARDX dossier
Share

The ARDX intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.